Bristol Myers ends blood cancer drug deal with cell therapy maker Cellares - Reuters
Bristol Myers ends blood cancer drug deal with cell therapy maker Cellares Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMixgFBVV95cUxQblFOZVZ1VkVaUFlZTURQRmJGMFpQNnhBTjRmWGlXU3M0ekx1UEoxUFFhNGxic3EzOFNtTTVCNE9DeU4xakhsQWVZZUhWNkdnUmIxakF5TlZiN1VsLTVYTTlMbllsZXBMYTJFM2lDdDhONVV3NWVlSWp1dHB5N25hQXRfYjZBTHRWeG5tUjBHYnQ1QWU3WFRSOFEwODVhazV6NXRfLTZJTmNPN19iTG9KcjVMREl5UWpwN01vekVacGNleVJtclE?oc=5" target="_blank">Bristol Myers ends blood cancer drug deal with cell therapy maker Cellares</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
US FDA advisers endorse Grail cancer test's benefits in key vote - Reuters
US FDA advisers endorse Grail cancer test's benefits in key vote Reuters
September 23, 2026 at 11:03 PMCD&R and Warburg Pincus in joint bid for Canaccord Wealth, sources say - Reuters
CD&R and Warburg Pincus in joint bid for Canaccord Wealth, sources say Reuters
September 22, 2026 at 04:21 PMMerck's drug for diabetes-related eye disease meets trial goal - Reuters
Merck's drug for diabetes-related eye disease meets trial goal Reuters
September 24, 2026 at 02:52 PMUS FDA approves AbbVie's drug for Parkinson's disease - reuters.com
US FDA approves AbbVie's drug for Parkinson's disease reuters.com
September 25, 2026 at 10:57 PMCancer patient told she will get drug which could make her life longer
Patients in England with an incurable breast cancer can now access a life-extending drug on the NHS, two years after it was deemed too expensive by a health body.
September 17, 2026 at 05:28 AMChina's InnoCare, Eli Lilly sign collaboration deal worth up to $3.35 billion - Reuters
China's InnoCare, Eli Lilly sign collaboration deal worth up to $3.35 billion Reuters
September 24, 2026 at 04:55 AM